Alnylam Pharma (ALNY) Tops Q3 EPS by 21c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Goldman says this FX trade is the best hedge for the AI drawdown
Tweet
Share
E-mail
Get Alerts ALNY Hot Sheet
Price: $161.08 --0%
Financial Fact:
Total other income (expense): 2.32M
Today's EPS Names:
KEEL, SENEA, XFOR, More
Financial Fact:
Total other income (expense): 2.32M
Today's EPS Names:
KEEL, SENEA, XFOR, More
Join SI Premium – FREE
Alnylam Pharma (NASDAQ: ALNY) reported Q3 EPS of ($1.06), $0.21 better than the analyst estimate of ($1.27). Revenue for the quarter came in at $17.1 million versus the consensus estimate of $24.65 million.
For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Icahn Enterprises L.P. (INGR) Tops Q3 EPS by 12c ; Offers Guidance
- Shattuck Labs, Inc. (STTK) Misses Q3 EPS by 3c
- Appian Corporation (APPN) Tops Q3 EPS by 18c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
